Speaking of Alphabet, it would definitely be possible for both Microsoft and Alphabet to appreciate 50% in 2026. While ...
A year and a half later, the team has reported – again in Nature ("Targeting protein-ligand neosurfaces with a generalizable deep learning tool") – an exciting advancement of this technology. They ...
Many drug and antibody discovery pathways focus on intricately folded cell membrane proteins: when molecules of a drug candidate bind to these proteins, like a key going into a lock, they trigger ...
In 2023, scientists in the joint School of Engineering and School of Life Sciences Laboratory of Protein Design and Immunoengineering (LPDI), led by Bruno Correia, published in Nature a deep-learning ...